Back
ImmunityBio Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
29
IBRX
ImmunityBio
Last Price:
$2.62
Seasonality Move:
3.53%
Buy
60
BMRN
Biomarin Pharmaceutical
Last Price:
$65.65
Seasonality Move:
5.39%
Sell
29
ImmunityBio (IBRX)
is a Sell
Is ImmunityBio a Buy, Sell or Hold?
-
The current ImmunityBio [IBRX] share price is $2.62. The Score for IBRX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
IBRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
-
The current Biomarin Pharmaceutical [BMRN] share price is $65.69. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IBRX Stock Price Chart
What is ImmunityBio's stock price today?
-
The ImmunityBio share price today is $2.62Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IBRX is experiencing selling pressure, which indicates risk of future bearish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $65.69Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
IBRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.58 | Sell |
Relative Strength Index (14 RSI): | 28.04 | Sell |
Chaikin Money Flow: | -6222154 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.27 - 5.23) | Sell |
Bollinger Bands (100): | (3.36 - 4.96) | Sell |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 48.8 | Sell |
Chaikin Money Flow: | 1709604 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (63.56 - 66.54) | Buy |
Bollinger Bands (100): | (64.13 - 84.07) | Sell |
IBRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.86 | Sell |
20-day SMA: | 4.08 | Sell |
50-day SMA: | 4.46 | Sell |
200-day SMA: | 5.22 | Sell |
8-day EMA: | 3.04 | Sell |
20-day EMA: | 3.74 | Sell |
50-day EMA: | 4.2 | Sell |
200-day EMA: | 4.59 | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.79 | Sell |
20-day SMA: | 65.64 | Buy |
50-day SMA: | 66.69 | Sell |
200-day SMA: | 78.92 | Sell |
8-day EMA: | 65.67 | Buy |
20-day EMA: | 65.74 | Sell |
50-day EMA: | 67.62 | Sell |
200-day EMA: | 77.02 | Sell |
ImmunityBio Earnings Growth & IBRX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.32 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.90 per share.
ImmunityBio Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |